These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 38630890)

  • 1. Successful Treatment of Carbapenem-Resistant Acinetobacter baumannii Meningitis With Sulbactam-Durlobactam.
    Tamma PD; Immel S; Karaba SM; Soto CL; Conzemius R; Gisriel E; Tekle T; Stambaugh H; Johnson E; Tornheim JA; Simner PJ
    Clin Infect Dis; 2024 Oct; 79(4):819-825. PubMed ID: 38630890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment-emergent cefiderocol resistance in carbapenem-resistant
    Huang E; Thompson RN; Moon SH; Keck JM; Lowry MS; Melero J; Jun S-R; Rosenbaum ER; Dare RK
    Antimicrob Agents Chemother; 2024 Jul; 68(7):e0029024. PubMed ID: 38809000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hetero-antagonism of avibactam and sulbactam with cefiderocol in carbapenem-resistant
    Wong O; Mezcord V; Lopez C; Traglia GM; Pasteran F; Tuttobene MR; Corso A; Tolmasky ME; Bonomo RA; Ramirez MS
    Microbiol Spectr; 2024 Oct; 12(10):e0093024. PubMed ID: 39162493
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Karlowsky JA; Hackel MA; McLeod SM; Miller AA
    Antimicrob Agents Chemother; 2022 Sep; 66(9):e0078122. PubMed ID: 36005804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of Sulbactam-Durlobactam and Comparators Against a National Collection of Carbapenem-Resistant
    Petropoulou D; Siopi M; Vourli S; Pournaras S
    Front Cell Infect Microbiol; 2021; 11():814530. PubMed ID: 35127562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulbactam-durlobactam: a β-lactam/β-lactamase inhibitor combination targeting
    McLeod SM; O'Donnell JP; Narayanan N; Mills JP; Kaye KS
    Future Microbiol; 2024; 19(7):563-576. PubMed ID: 38426849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution, control and success of combination therapy with Ampicilin-sulbactam/Ceftazidime-Avibactam during a Carbapenem-Resistant Acinetobacter baumannii outbreak in burn Intensive Care Unit.
    Dudoignon E; Caméléna F; Lafaurie M; Deniau B; Chaussard M; Coutrot M; Guillemet L; Cupaciu A; Pharaboz A; Boutin L; Benyamina M; Chaouat M; Mimoun M; Merimèche M; Mebazaa A; Plaud B; Berçot B; Dépret F; Mellon G
    Eur J Clin Microbiol Infect Dis; 2024 Jul; 43(7):1453-1459. PubMed ID: 38676856
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Santerre Henriksen A; Jeannot K; Oliver A; Perry JD; Pletz MW; Stefani S; Morrissey I; Longshaw C;
    Microbiol Spectr; 2024 Apr; 12(4):e0383623. PubMed ID: 38483164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulbactam-Durlobactam, A Novel Drug for the Treatment of Multidrug Resistant
    Velmurugan H; Venkatesan S; Meles HN; Neelambaram K; Thangaraju P
    Infect Disord Drug Targets; 2024; 24(6):e220124225835. PubMed ID: 38258766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Successful treatment of a patient with multidrug resistant Acinetobacter baumannii meningitis with high dose ampicillin-sulbactam].
    Sayin Kutlu S; Saçar S; Süzer T; Cevahir N; Okke D; Dirgen Caylak S; Turgut H
    Mikrobiyol Bul; 2008 Apr; 42(2):353-8. PubMed ID: 18697435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induced Heteroresistance in Carbapenem-Resistant
    Mezcord V; Escalante J; Nishimura B; Traglia GM; Sharma R; Vallé Q; Tuttobene MR; Subils T; Marin I; Pasteran F; Actis LA; Tolmasky ME; Bonomo RA; Rao G; Ramirez MS
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511511
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    McLeod SM; Moussa SH; Hackel MA; Miller AA
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31988095
    [No Abstract]   [Full Text] [Related]  

  • 13. In vitro activity of cefiderocol against carbapenem-resistant Acinetobacter baumannii carrying various β-lactamase encoding genes.
    Uskudar-Guclu A; Danyildiz S; Mirza HC; Akcil Ok M; Basustaoglu A
    Eur J Clin Microbiol Infect Dis; 2024 Jun; 43(6):1171-1179. PubMed ID: 38652417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sulbactam-durlobactam: A Step Forward in Treating Carbapenem-Resistant Acinetobacter baumannii (CRAB) Infections.
    Watkins RR; Bonomo RA
    Clin Infect Dis; 2023 May; 76(Suppl 2):S163-S165. PubMed ID: 37125465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of Cefiderocol, a Novel Siderophore Cephalosporin, against Multidrug Resistant Acinetobacter baumannii Clinical Isolates in Japan.
    Kimura Y; Hatayama N; Sato Y; Nishida S; Yoshino Y
    Jpn J Infect Dis; 2024 May; 77(3):178-181. PubMed ID: 38296540
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Iovleva A; McElheny CL; Fowler EL; Cober E; Herc ES; Arias CA; Hill C; Baum K; Fowler VG; Chambers HF; Greenwood-Quaintance KE; Patel R; van Duin D; Bonomo RA; Doi Y
    Antimicrob Agents Chemother; 2024 Mar; 68(3):e0125823. PubMed ID: 38289078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of sulbactam-durlobactam against carbapenem-resistant Acinetobacter baumannii and mechanisms of resistance.
    Findlay J; Poirel L; Bouvier M; Nordmann P
    J Glob Antimicrob Resist; 2022 Sep; 30():445-450. PubMed ID: 35618210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of skin and soft tissue infection due to carbapenem-resistant Acinetobacter baumannii by ampicillin-sulbactam and meropenem combination therapy.
    Hiraki Y; Yoshida M; Masuda Y; Inoue D; Tsuji Y; Kamimura H; Karube Y; Takaki K; Kawano F
    Int J Infect Dis; 2013 Dec; 17(12):e1234-6. PubMed ID: 23791858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Navigating Available Treatment Options for Carbapenem-Resistant Acinetobacter baumannii-calcoaceticus Complex Infections.
    Shields RK; Paterson DL; Tamma PD
    Clin Infect Dis; 2023 May; 76(Suppl 2):S179-S193. PubMed ID: 37125467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mechanism of drug resistance of carbapenems-resistant Acinetobacter baumannii and the application of a combination of drugs in vitro].
    Zhao C; Xie W; Zhang W; Ye Z; Wu H
    Zhonghua Shao Shang Za Zhi; 2014 Apr; 30(2):166-70. PubMed ID: 24989663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.